Research Projects

University of Ljubljana, located in a low R&I performing country, will partner with two internationally-leading organisations, the Medical University of Graz and KU Leuven, to expand the support and coordination capacity for national and European research in ageing-related decrease in brain functions leading to dementia. By 2025 more than 25% of...

Transport proteins are the gate-keepers of our cells, effectively controlling the flow of nutrients and other molecules across the cell membrane. With over 400 members, solute carriers represent the largest class of transport proteins. Yet although they have been implicated in diseases ranging from Alzheimer’s disease and amyotrophic lateral...

People suffering from brain degeneration like Alzheimer dementia can be helped by stimulation of their memory, meaningful activities and an improved level of physical activity in which all the help of many people around them is wanted for everyday life. The ReMIND project wants to develop a robot and tablet that can support the people with dementia...

Amyloid diseases are of increasing concern in our aging society. These diseases all involve the aggregation of misfolded proteins, called amyloid, which are specific for each disease (PrP for Prion, Abeta for Alzheimer's). When misfolded these proteins propagate the abnormal configuration and aggregate to others, forming very long polymers also...

The main objective of Many-Me is to offer patients in different stages of dementia a friendly and enjoyable environment supported by ICT solutions, empowering them to self-manage their condition by engaging and learning from people in a similar situation, make friends and attend support groups, test and adopt routines or techniques that help memory...

Due to growing life expectancy and unhealthy lifestyles, dementia is a fast growing chronic disease that affects the behaviour and communication abilities of people living with this neurological disorder. Caregivers are often challenged by this fact, which could lead to stress, helplessness, aggressive situations and caregiver burnout. The SUCCESS...

The detection of biomarkers in body fluids is of great importance for disease early diagnosis. The clinical practice uses typically immunoassay methods (e.g. ELISA, Enzyme-Linked Immuno Sorbent Assay, and related techniques) for biomarker determination. Unfortunately, these techniques fail dramatically in a wide variety of cases where the...

Recent Nobel Prize-winning discoveries on circadian clock (CC) have laid the foundation for ground-breaking approaches to treat many diseases, including Alzheimer’s disease (AD). AD is a current public health priority. Amplifying the demographic burden of the rising numbers of patients is the low success rate of AD therapies. Given that CC genes...

There are an increasing number of people across Europe with debilitating speech pathologies (e.g., due to stroke, Parkinson's, etc). These groups face communication problems that can lead to social exclusion. They are now being further marginalised by a new wave of speech technology that is increasingly woven into everyday life but which is not...

Mutations in certain proteins can cause their misfolding and aggregation, posing a potential threat to the health of an organism. Protein aggregation is counteracted by protein quality control (PQC) mechanisms that reduce the amounts of damaged molecules. As we age, however, the crucial surveillance mechanisms weaken and become less effective...

The DementiA Research Enabled by IT project responds to the European Parliament's 2011 resolution for a European Initiative on Alzheimer's disease and other dementias, and the EU Year of the Brain 2014 Initiative. It delivers the first patient-specific predictive models for early differential diagnosis of dementias and their evolution. Its...